卵巢浆液性囊腺瘤与囊腺纤维瘤的生长速率
该研究回顾性分析了经手术切除的卵巢浆液性囊腺瘤和囊腺纤维瘤的影像生长速率,共146例符合纳入标准。结果显示53.4%的肿瘤体积倍增时间小于3年,15.1%在3至5年之间,31.5%大于5年或未见增长。
要点
- 卵巢浆液性囊腺瘤/囊腺纤维瘤中53.4%体积倍增时间小于3年。
- 31.5%的肿瘤体积倍增时间大于5年或未见增长。
- 超声、MRI或CT均可用于测量并计算体积倍增时间。
关键影像表现/征象
- 肿瘤体积通过三次正交测量相乘再乘以0.52计算。
- 体积倍增时间分为五类:小于1年、1至3年、3至5年、5至10年、无增长(倍增时间大于10年或体积缩小)。
诊断标准与关键数值
- 倍增时间小于1年者40例(27.4%)。
- 倍增时间1至3年者38例(26.0%)。
- 倍增时间3至5年者22例(15.1%)。
- 倍增时间5至10年者10例(6.8%)。
- 无增长者36例(24.7%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: We analyzed growth rates of benign ovarian serous cystadenomas and cystadenofibromas to understand what percentage would show a volume doubling time (DT) of less than 3 years, between 3 and 5 years, or greater than 5 years.
METHODS: We retrospectively reviewed pathology records (January 1, 2014, to June 30, 2019) to find all surgically excised ovarian serous cystadenomas and cystadenofibromas. Imaging records were then reviewed to identify those that had been confidently identified with ultrasound imaging, magnetic resonance imaging, or computed tomography at least twice before surgical removal, with at least a 60-day interval between studies. Three orthogonal measurements were recorded on the first and last imaging studies on which the mass was detected, with volume calculations by the prolate formula (product of 3 measurements multiplied by 0.52). The volume DT was calculated and grouped into 1 of 5 categories: (1) DT of less than 1 year; (2) DT of 1 to 3 years; (3) DT of 3 to 5 years; (4) DT of 5 to 10 years; and (5) no growth (any mass with a DT >10 years or showing a decrease in volume).
RESULTS: A total of 102 of 536 cystadenomas and 44 of 227 cystadenofibromas met inclusion criteria. Of the 146 tumors, 40 (27.4%) had a DT of less than 1 year; 38 (26.0%) had a DT of 1 to 3 years; 22 (15.1%) had a DT of 3 to 5 years; 10 (6.8%) had a DT of 5 to 10 years; and 36 (24.7%) showed no growth.
CONCLUSIONS: A total of 53.4% of ovarian serous cystadenomas/cystadenofibromas have a DT of less than 3 years; 15.1% have a DT between 3 and 5 years; and 31.5% have a DT of greater than 5 years or show no growth.
引用
- Frederick RP, Patel AG, Young SW, et al. Growth Rate of Ovarian Serous Cystadenomas and Cystadenofibromas. J Ultrasound Med. 2020. PMID: 33320368. doi:10.1002/jum.15597
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。